WuXi Biologics inspection raises prospects for getting off US 'unverified list' — report
WuXi Biologics may be inching closer to working its way off the US “unverified list,” an event that wiped out some $10 billion in market value earlier this year.
Reuters is reporting that Chinese officials allowed a US export control officer to conduct an inspection in the city of WuXi, which the wire service identified as WuXi Biologics, citing an unnamed source. And the report also quoted a US export control officer who noted that an inspection in Anhui may follow, unless Covid interferes again.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.